Neorelief For Muscle Crampling And Restlessness Gel
NDC Package 58368-002-02
Package Information
Neorelief For Muscle Crampling And Restlessness (topical gel for muscle cramping and restlessness) gel is adults and children 2 years of age and older, apply a thin layer of gel on clean skin to cover the affected area. This formulation utilizes a gel delivery system. Marketed by Biolyte Laboratories, Llc, this product is identified by NDC 58368-002.
Identification & Billing
Clinical Specifications
- ARNICA MONTANA 4 [hp_X]/g
- ARTEMISIA CINA PRE-FLOWERING TOP 8 [hp_X]/g
- ATROPA BELLADONNA ROOT 4 [hp_X]/g
- BLACK COHOSH 4 [hp_X]/g
- CAUSTICUM 4 [hp_X]/g
- FRANGULA CALIFORNICA BARK 4 [hp_X]/g
- HYPERICUM PERFORATUM 4 [hp_X]/g
- JATROPHA CURCAS SEED 8 [hp_X]/g
- LYCOPODIUM CLAVATUM SPORE 4 [hp_X]/g
- POTASSIUM BROMIDE 4 [hp_X]/g
- POTASSIUM CARBONATE 4 [hp_X]/g
- PSEUDOGNAPHALIUM OBTUSIFOLIUM 4 [hp_X]/g
- RUTA GRAVEOLENS FLOWERING TOP 4 [hp_X]/g
- SCUTELLARIA LATERIFLORA 4 [hp_X]/g
- STRYCHNOS IGNATII SEED 4 [hp_X]/g
- TARAXACUM OFFICINALE 4 [hp_X]/g
- VALERIAN 8 [hp_X]/g
- VERATRUM ALBUM ROOT 8 [hp_X]/g
Regulatory & Marketing
Hierarchy Structure
- 58368 - Biolyte Laboratories, Llc
- 58368-002 - Neorelief For Muscle Crampling And Restlessness
- 58368-002-02 - 56.7 g in 1 BOTTLE, PUMP
- 58368-002 - Neorelief For Muscle Crampling And Restlessness
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 58368-002-02 identifies a specific commercial package of 56.7 g in 1 bottle, pump of Neorelief For Muscle Crampling And Restlessness, a human over the counter drug labeled by Biolyte Laboratories, Llc. This gel is formulated for topical use and contains arnica montana; artemisia cina pre-flowering top; atropa belladonna root; black cohosh; causticum; frangula californica bark; hypericum perforatum; jatropha curcas seed; lycopodium clavatum spore; potassium bromide; potassium carbonate; pseudognaphalium obtusifolium; ruta graveolens flowering top; scutellaria lateriflora; strychnos ignatii seed; taraxacum officinale; valerian; veratrum album root as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Biolyte Laboratories, Llc on February 01, 2017. The current certification is valid through December 31, 2027.
How is this Biolyte Laboratories, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 58368000202. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.